IPS Medication

IDMP PhPID Level 1 (Implies ingredients) or any equivalent Pharmaceutical Product identifier.

Pharmaceutical Product Identifier (PhPID): Uniquely identifies medicinal product based on the generic composition, such as ingredients and route of administration, separate from any other details such as regulatory authorisation, organisation, packaging or naming. The PhPID can be specified at various levels of detail for a given Pharmaceutical Product.

IDMP PhPID Level 2 (Implies ingredients and strength) or any equivalent Pharmaceutical Product identifier.

Pharmaceutical Product Identifier (PhPID): Uniquely identifies medicinal product based on the generic composition, such as ingredients and route of administration, separate from any other details such as regulatory authorisation, organisation, packaging or naming. The PhPID can be specified at various levels of detail for a given Pharmaceutical Product.

IDMP PhPID Level 3 (Implies ingredients and dose form) or any equivalent Pharmaceutical Product identifier.

Pharmaceutical Product Identifier (PhPID): Uniquely identifies medicinal product based on the generic composition, such as ingredients and route of administration, separate from any other details such as regulatory authorisation, organisation, packaging or naming. The PhPID can be specified at various levels of detail for a given Pharmaceutical Product.

IDMP PhPID Level 4 (Implies ingredients, strength, and dose form) or any equivalent Pharmaceutical Product identifier.

Pharmaceutical Product Identifier (PhPID): Uniquely identifies medicinal product based on the generic composition, such as ingredients and route of administration, separate from any other details such as regulatory authorisation, organisation, packaging or naming. The PhPID can be specified at various levels of detail for a given Pharmaceutical Product.

IDMP Medicinal Product Identifier (MPID) or any equivalent Medicinal Product Identifier.

IDMP MPID uniquely identifies a Medicinal Product, reflecting (but not replacing) any other authorisation numbers allocated by a regulator.

MPID implies one (set of) PhPID. The MPID shall use a common segment pattern related to a Medicinal Product, which when each segment is valued shall define a specific MPID concept. The pattern is: • a) Country code segment (ISO 3166-1 alpha-2 code elements); • b) Marketing Authorization Holder (Organization Identifier) code segment; • c) Medicinal Product code segment (Unique Medicinal Product Identifier). • Any change of the values related to these three code segments shall result in the assignment of a new MPID.

IDMP Packaged Medicinal Product Identifier or any equivalent Packaged Medicinal Product Identifier.

Uniquely identifies a Medicinal Product based on its packaging. This implies one MPID can be associated with more than one PCID, if the same Medicinal Product has more than one type of package;

The PCID shall use a common segment pattern related to a package of a Medicinal Product, which when each segment is valued, shall define a specific PCID concept. The pattern is: • a) MPID for the Medicinal Product • b) package description code segment, which refers to a unique identifier for each package.

ATC classification for medication product

Describes the form of the item. Powder; tablets; capsule.

Administrable Pharmaceutical Dose Form. This code represents the form of the medication (e.g. tablet, capsule, liquid)

Since the EDQM Standards Terms, together with UCUM, is one of the IDMP terminologies actually available for usage, this code system has been selected as referecne terminology for representing Pharmaceutical Dose forms;Pakages and Route of Administration.

It is known that also alternative jurisdictional and international terminologies are known to be used for this concept domain, as NCI or SNOMED CT.

The IDMP ISO 11238 standard addresses the identification and exchange of regulated information on substances. The Global Ingredient Archival System (GInAS) will provide a common global identifier for all of the substances used in medicinal products, providing a definition of substances globally consistent with this standard. Those identifiers however are yet available for concrete usage, therefore in this version of the template, SNOMED CT has been chosen as reference terminology also for the active substances. This choice will be revised based on the availability and the maturity of GInAS.